Quotazioni in diretta

ALLO Allogene Therapeutics Inc

2,73

-0,13 (-4,55%)

11 Mag 2024 - Chiuso

Dati in Delay di 15 minuti

Massive Gaming Celebrates Global Launch of House of Blackjack with USDC Earning Race

Sydney, Australia, July 10th, 2023, Chainwire Massive Gaming has announced the launch of House of Blackjack, a realistic Vegas-style online ... Read more
https://www.valuewalk.com/massive-gaming-celebrates-global-launch-of-house-of-blackjack-with-usdc-earning-race/

Grafico Azioni Allogene Therapeutics (NASDAQ:ALLO)
Storico
Da Apr 2024 a Mag 2024

Clicca qui per i Grafici di Allogene Therapeutics

Grafico Azioni Allogene Therapeutics (NASDAQ:ALLO)
Storico
Da Mag 2023 a Mag 2024

Clicca qui per i Grafici di Allogene Therapeutics

Notizie Allogene Therapeutics Inc - ALLO

Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update
Lunedì 6 Maggio 2024 (6 giorni fa) • GlobeNewswire Inc.

Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma
Venerdì 26 Aprile 2024 (2 settimane fa) • GlobeNewswire Inc.

Allogene Therapeutics Announces Q2 Investor Conference Participation
Martedì 9 Aprile 2024 (1 mese fa) • GlobeNewswire Inc.

Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
Giovedì 14 Marzo 2024 (2 mesi fa) • GlobeNewswire Inc.

Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to Support Advancement of Next-Generation Allogeneic CAR T Platform in Autoimmune Disease
Martedì 12 Marzo 2024 (2 mesi fa) • GlobeNewswire Inc.

Allogene Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update
Martedì 5 Marzo 2024 (2 mesi fa) • GlobeNewswire Inc.

Allogene Therapeutics Announces Participation in the 44th Annual TD Cowen Health Care Conference
Mercoledì 28 Febbraio 2024 (2 mesi fa) • GlobeNewswire Inc.

Form 8-K - Current report
Venerdì 16 Febbraio 2024 (3 mesi fa) • Edgar (US Regulatory)

Allogene Therapeutics to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments Related to the December 2020 Formation of the Allogene Overland Biopharm Joint Venture in Asia
Venerdì 16 Febbraio 2024 (3 mesi fa) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 31 Gennaio 2024 (3 mesi fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 24 Gennaio 2024 (4 mesi fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Lunedì 22 Gennaio 2024 (4 mesi fa) • Edgar (US Regulatory)

Più Allogene Therapeutics Inc Articoli Notizie

Pharmaceutical Select Po...

Delayed Upgrade Clock

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea